Advanced Sarcoma Clinical Trial
Official title:
A Pilot Study of Lenvatinib Plus Pembrolizumab in Patients With Advanced Sarcoma
The purpose of this study is to find out whether combining the study drugs, lenvatinib and pembrolizumab, is a safe and effective treatment for metastatic soft tissue sarcomas that cannot be removed with surgery.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05448820 -
YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma
|
Phase 1/Phase 2 | |
Terminated |
NCT03652298 -
Effects of a Neuroscience-based Technique on Cancer Patients Announced of a Palliative Disease Progression and Partners
|
Phase 2 | |
Withdrawn |
NCT05238831 -
SMMART Adaptive Clinical Treatment (ACT) Trial
|
Early Phase 1 | |
Active, not recruiting |
NCT04242238 -
Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas
|
Phase 1 | |
Recruiting |
NCT06087341 -
A Phase I Trial of Memory T Cells Expressing an NKG2D Chimeric Antigen Receptor in Children, Adolescents and Young Adults With Advanced Sarcoma
|
Phase 1 | |
Completed |
NCT00439686 -
Study of ZIO-201 in Advanced Sarcoma
|
Phase 1/Phase 2 |